May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety ...
April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...
April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...
March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...
March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first ...
March 18, 2024 — Conformal Medical, Inc. announced that the CLAAS System was featured in a podium presentation at the Ca ...
February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...
February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...
February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...
February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
January 31, 2024 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) appro ...